Similar articles

• Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model.

  Umehara T, Sudoh M, Yasui F, Matsuda C, Hayashi Y, Chayama K, Kohara M. Umehara T, et al. Biochem Biophys Res Commun. 2006 Jul 21;346(1):67-73. doi: 10.1016/j.bbrc.2006.05.085. Epub 2006 May 24. Biochem Biophys Res Commun. 2006. PMID: 16750511
• Myriocin, an inhibitor of serine palmitoyl transferase, impairs the uptake of transferrin and low-density lipoprotein in mammalian cells.

  Meyer SG, Wendt AE, Scherer M, Liebisch G, Kerkweg U, Schmitz G, de Groot H. Meyer SG, et al. Arch Biochem Biophys. 2012 Oct 1;526(1):60-8. doi: 10.1016/j.abb.2012.07.006. Epub 2012 Jul 24. Arch Biochem Biophys. 2012. PMID: 22841978
• Prevention of HCV replication by serine palmitoyltransferase inhibition.

  Lowe AW, Moseley RH. Lowe AW, et al. Gastroenterology. 2013 Oct;145(4):701-2. Gastroenterology. 2013. PMID: 24187689 No abstract available.
• Cellular models for the screening and development of anti-hepatitis C virus agents.

  Gondeau C, Pichard-Garcia L, Maurel P. Gondeau C, et al. Pharmacol Ther. 2009 Oct;124(1):1-22. doi: 10.1016/j.pharmthera.2009.05.010. Epub 2009 Jun 23. Pharmacol Ther. 2009. PMID: 19555718 Review.
• Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases.

  Nijhuis M, van Maarseveen NM, Boucher CA. Nijhuis M, et al. Handb Exp Pharmacol. 2009;(189):299-320. doi: 10.1007/978-3-540-79086-0_11. Handb Exp Pharmacol. 2009. PMID: 19048205 Review.